
Equine Juvenile Spinocerebellar Ataxia
Turnaround: 3-5 business daysTurnaround: 7-10 business days
Price: $40.00Price: £30.00
Breeds: Appaloosa/Quarter Horse, Arabian/Quarter Horse, Quarter Cross, Quarter Horse, Quarter Pony, Quarter/Paint Horse, Quarter/Stock Horse, Quarter/Thoroughbred
Description
Equine Juvenile Spinocerebellar Ataxia (EJSCA) is a inherited neurological disorder affecting young horses, characterized by progressive incoordination and loss of balance. Testing for this condition is now included across all relevant genetic screening panels to help breeders identify carriers and prevent the disease in future offspring.
What is Equine Juvenile Spinocerebellar Ataxia (EJSCA)?
Equine Juvenile Spinocerebellar Ataxia (EJSCA) is a severe genetic condition that affects the horse's central nervous system—specifically the cerebellum and spinal cord—which coordinate motor control and balance.
-
Symptoms: Affected foals typically present within the first few months to a year of life. Common signs include gait abnormalities, severe clumsiness (ataxia), loss of balance, intention tremors, and a wide-based stance.
-
Progression: The disorder is progressive. As the ataxia worsens, affected animals become increasingly uncoordinated and eventually lose the ability to stand or navigate safely.
-
Inheritance Pattern: EJSCA is inherited as an Autosomal Recessive trait. A horse must inherit two copies of the mutated gene (one from each parent) to be clinically affected by the disease.
Understanding Your Test Results
Genetic testing identifies whether a horse carries the mutated gene responsible for EJSCA. Because it follows an autosomal recessive inheritance model, results will fall into one of three categories:
| Result | Status | Meaning & Breeding Recommendations |
| N/N | Clear / Normal | Does not carry the EJSCA mutation. The horse will not develop the disease and cannot pass the mutation on to offspring. Safe to mate with any horse. |
| N/EJSCA | Carrier | Carries one copy of the mutation. The horse is clinically healthy and will not show symptoms. However, there is a 50% chance of passing the mutation to future foals. Do not mate with another carrier. |
| EJSCA/EJSCA | Affected | Carries two copies of the mutation and will develop clinical signs of EJSCA. |
Breeding Recommendations
To prevent producing affected foals:
-
Clear $\times$ Clear (N/N $\times$ N/N): 100% of offspring will be Clear (N/N).
-
Clear $\times$ Carrier (N/N $\times$ N/EJSCA): 50% Clear (N/N), 50% Carrier (N/EJSCA). No foals will be affected.
-
Carrier $\times$ Carrier (N/EJSCA $\times$ N/EJSCA): Avoid this pairing. There is a 25% chance of producing an affected foal (EJSCA/EJSCA), a 50% chance of a carrier, and a 25% chance of a clear foal.
By including EJSCA testing in our standard equine panels, breeders can make informed, responsible pairing decisions to completely eliminate the risk of producing affected foals.
Possible Results
| Genotype | Description |
|---|---|
| JSA/JSA | Affected: Horse is has two copies of the JSA gene mutation and will exhibit signs of the disease. Horse will pass the gene to all offspring. |
| JSA/N | Carrier: Horse has one copy of the JSA mutation. Horse has a 50% chance of passing this mutated gene on to any offspring. |
| N/N | Clear: Horse is negative for the JSA gene mutation. |